JC

James J. Cunningham

ST Sirna Therapeutics: 8 patents #14 of 124Top 15%
GS G.D. Searle: 3 patents #254 of 659Top 40%
Merck: 1 patents #5,419 of 9,382Top 60%
Pfizer: 1 patents #3,022 of 5,153Top 60%
📍 Wayne, PA: #47 of 493 inventorsTop 10%
🗺 Pennsylvania: #5,969 of 74,527 inventorsTop 9%
Overall (All Time): #368,026 of 4,157,543Top 9%
13
Patents All Time

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
11932854 RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) Mark Cancilla, William Michael Flanagan, Henry J. Haringsma, Denise M. Kenski, Matthew G. Stanton +2 more 2024-03-19
11193126 RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) Mark Cancilla, William Michael Flanagan, Henry J. Haringsma, Denise M. Kenski, Matthew G. Stanton +2 more 2021-12-07
10246714 RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) Duncan Brown, Marian Gindy, Victoria Pickering, Matthew G. Stanton, Steven M. Stirdivant +1 more 2019-04-02
9970005 RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) Mark Cancilla, William Michael Flanagan, Henry J. Haringsma, Denise M. Kenski, Matthew G. Stanton +2 more 2018-05-15
9850491 RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) Duncan Brown, Marian Gindy, Victoria Pickering, Matthew G. Stanton, Steven M. Stirdivant +1 more 2017-12-26
9447420 RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA) Duncan Brown, Marian Gindy, Victoria Pickering, Matthew G. Stanton, Steven M. Stirdivant +1 more 2016-09-20
9260471 RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) Mark Cancilla, Michael W. Flanagan, Henry J. Haringsma, Denise M. Kenski, Matthew G. Stanton +2 more 2016-02-16
8835623 RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) Duncan Brown, Marian Gindy, Victoria Pickering, Matthew G. Stanton, Steven M. Stirdivant +1 more 2014-09-16
8518907 RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) Duncan Brown, Marian Gindy, Victoria Pickering, Matthew G. Stanton, Steven M. Stirdivant +1 more 2013-08-27
6916800 Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent John McKearn, Gary B. Gordon, Stephen Gately, Alane T. Koki, Jaime Masferrer 2005-07-12
6858598 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia John McKearn, Gary B. Gordon, Stephen Gately, Alane T. Koki, Jaime Masferrer 2005-02-22
6833373 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia John McKearn, Gary B. Gordon, Stephen Gately, Alane T. Koki, Jaime Masferrer 2004-12-21
6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia John McKearn, Gary B. Gordon, Stephen Gately, Alane T. Koki, Jaime Masferrer 2004-02-10